- 专利标题： COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS
-
申请号： US15325576申请日： 2015-07-16
-
公开(公告)号： US20170143780A1公开(公告)日： 2017-05-25
- 发明人: Laurence Zitvogel , Xavier Preville , Laetitia Fend
- 申请人： Institut Gustave-Roussy , Transgene SA
- 申请人地址： FR Villejuif FR Illkirch Graffenstaden
- 专利权人： Institut Gustave-Roussy,Transgene SA
- 当前专利权人： Institut Gustave-Roussy,Transgene SA
- 当前专利权人地址： FR Villejuif FR Illkirch Graffenstaden
- 优先权： EP1430615.4 20140716
- 国际申请： PCT/EP2015/066353 WO 20150716
- 主分类号： A61K35/768
- IPC分类号： A61K35/768 ; A61K38/19 ; A61K9/00 ; A61K39/395 ; C12N7/00 ; C07K16/28
摘要：
The present invention provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulator(s) for use for the treatment of a proliferative disease such as cancer. It also relates to a kit comprising said oncolytic virus and said one or more immune checkpoint modulator(s) in separate containers. It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and said one or more immune checkpoint modulator(s).
公开/授权文献
信息查询
IPC分类:
